AlphaStocks

BSX vs FTI

BOSTON SCIENTIFIC CORP vs TechnipFMC plc — Side-by-Side Stock Comparison

BSX

BOSTON SCIENTIFIC CORP

3.7

Weak

$56.01

FTI

TechnipFMC plc

8.3

Strong Buy

$73.95

BSX vs FTI: Which is the Better Investment?

BOSTON SCIENTIFIC CORP (BSX) scores 3.7/10 while TechnipFMC plc (FTI) scores 8.3/10 on AlphaStocks' composite model. TechnipFMC plc has the higher composite rating of Strong Buy. On a P/E basis, BOSTON SCIENTIFIC CORP trades at 28.9x, making it the more attractively priced of the two.

This comparison is algorithmically generated and is not financial advice.

MetricBSXFTI
Scores & Fundamentals
Composite Score3.7/108.3/10
RatingWeakStrong Buy
Price$56.01$73.95
P/E Ratio28.932.2
ROE12.2%28.8%
Market Cap$84B$30B
Fair Value$44.42$49.72
Dividend Yield
Sector Rank#906 of 1126#3 of 1126
Model Verdicts
PiotroskiStrongStrong
BuffettAttractiveStrong
GrahamCautionCaution
LynchNeutralStrong
GreenblattNeutralNeutral
View full BSXanalysis →View full FTIanalysis →
Compare any two stocks →

BSX vs FTI: Which Stock Scores Higher?

BOSTON SCIENTIFIC CORP (BSX) and TechnipFMC plc (FTI) are among the most compared stocks in the S&P 500. FTI currently leads with a composite score of 8.3/10 (Strong Buy) compared to BSX's 3.7/10 (Weak).

The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.

This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer